Emerging Treatments Over the Horizon for IBD
Jessica Allegretti, MD, MPH, and Edward Loftus Jr., MD, review emerging agents in the later phases for the management of IBD.
Unmet Needs in IBD Management
Expert gastroenterologists review the unmet needs in IBD management.
SEAVUE: Ustekinumab vs Adalimumab in Crohn Disease
Details of the head-to-head SEAVUE study of ustekinumab vs adalimumab for induction and maintenance therapy in patients with moderate to severe Crohn disease.
Biologics Used in the Treatment of IBD
A panel of experts share their experiences with the use of biologics for the treatment of inflammatory bowel diseases (IBDs).
Surgical Intervention in IBD
Indications for surgery in treating patients for ulcerative colitis (UC) and Crohn disease.
IBD Treatment: Approach in Moderate- to High-Risk Disease
Expert gastroenterologists share their perspectives regarding overall treatment approach in a patient with moderate- to high-risk inflammatory bowel disease.
IBD Treatment Options for Patients With Low-Risk Disease
Initial IBD therapy for a patient with low-risk disease and measuring treatment response on initial therapy.
Patient Factors to be Considered When Choosing Therapy for IBD
Important patient factors to consider other than severity of disease when choosing a therapeutic agent for inflammatory bowel disease.
Treatment Goals and Guidelines for Ulcerative Colitis and Crohn’s Disease
A panel of experts discuss the latest guidelines and how they make a treatment decision for patients with ulcerative colitis and Crohn’s disease.
Diagnosing Patients With Inflammatory Bowel Disease
Panel of gastroenterologists share their perspectives regarding the diagnostic work-up for patients who may have symptoms suggestive of IBD.
Incidence and Prevalence of Inflammatory Bowel Disease
Effect of age, gender, racial, and socioeconomic disparities on the incidence and prevalence of inflammatory bowel disease (IBD).
Risk Factors Associated With Inflammatory Bowel Disease
Expert gastroenterologists review the pathophysiology of inflammatory bowel disease (IBD) along with the associated risk factors.
2 Clarke Drive Cranbury, NJ 08512